COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03765788
Brief Title: A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis (TitAIN)

First Submitted : December 3, 2018
First Submitted that Met QC Criteria : December 4, 2018
First Posted : December 5, 2018

Last Update Submitted that Met QC Criteria : July 29, 2020
Last Update Posted : July 31, 2020